BCM
PRAH

BlueCrest Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

BlueCrest Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28,152
Closed -$3.1M – 1607
2018
Q3 		$3.1M Sell
28,152
-130,529
-82% -$13.6M 0.08% 166
2018
Q2 		$14.8M Buy
158,681
+153,756
+3,122% +$13.2M 0.38% 41
2018
Q1 		$409K Buy
+4,925
New +$438K 0.01% 878

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlueCrest Capital Management's PRAH Position: Q4 2018 in Review

BlueCrest Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 28,152 shares — an estimated $3.1M sold.

BlueCrest Capital Management first reported a position in PRAH in Q1 2018 and held it in 3 quarters. The position peaked at $14.8M in Q2 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • BlueCrest Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 28,152 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $3.1M.
  • BlueCrest Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 3 quarters.
  • BlueCrest Capital Management's PRA Health Sciences, Inc. position peaked at $14.8M in Q2 2018.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.